about
Oral Delivery of Protein Drugs Bioencapsulated in Plant CellsTranslation of Angiotensin-Converting Enzyme 2 upon Liver- and Lung-Targeted Delivery of Optimized Chemically Modified mRNAAngiotensin converting enzyme (ACE) and ACE2 bind integrins and ACE2 regulates integrin signalling.ACE2 deficiency enhances angiotensin II-mediated aortic profilin-1 expression, inflammation and peroxynitrite production.The ACE2/Apelin Signaling, MicroRNAs, and Hypertension.Loss of ACE2 exaggerates high-calorie diet-induced insulin resistance by reduction of GLUT4 in mice.Control of adipogenesis by the autocrine interplays between angiotensin 1-7/Mas receptor and angiotensin II/AT1 receptor signaling pathwaysRole of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart FailureIncreasing serum soluble angiotensin-converting enzyme 2 activity after intensive medical therapy is associated with better prognosis in acute decompensated heart failure.The ACE2 gene: its potential as a functional candidate for cardiovascular disease.Emerging markers in cardiovascular disease: where does angiotensin-converting enzyme 2 fit in?Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets.Protective axis of the renin-angiotensin system in the brain.Novel RAAS agonists and antagonists: clinical applications and controversies.Renin-angiotensin system: an old player with novel functions in skeletal muscle.Epigenetic regulation of angiotensin-converting enzyme 2 (ACE2) by SIRT1 under conditions of cell energy stress.Focus on Brain Angiotensin III and Aminopeptidase A in the Control of Hypertension.Alternative pathways for angiotensin II production as an important determinant of kidney damage in endotoxemia.Expression and activity of angiotensin-regulating enzymes is associated with prognostic outcome in clear cell renal cell carcinoma patients.Angiotensin II downregulates ACE2-mediated enhancement of MMP-2 activity in human cardiofibroblasts.MSCs modified with ACE2 restore endothelial function following LPS challenge by inhibiting the activation of RAS.Mesenchymal Stem Cells Overexpressing Angiotensin-Converting Enzyme 2 Rescue Lipopolysaccharide-Induced Lung Injury.In Silico Investigations of Chemical Constituents of Clerodendrum colebrookianum in the Anti-Hypertensive Drug Targets: ROCK, ACE, and PDE5.
P2860
Q28079063-8CDF5C38-A702-481D-8FDF-469AC905BC54Q33652543-0B292516-390F-4A26-B39C-DDB95EF8617AQ34241697-A8EE948F-D377-4BFC-A402-7C81995FA4AFQ34302600-FB41FB26-7664-43FD-B7ED-603C2BD3D733Q35178127-C9D8C447-2990-4266-9855-607E4970B40EQ36477252-8987CFBF-FFEF-4E6E-AB13-D5774C9A23D6Q36890554-0396D90A-BFC7-4D12-AF23-1DCD5B1C6BD0Q37081415-B114E1A2-8F5F-46BB-A43A-BD143DCC45C3Q37194713-8B707A37-7FCC-4309-91F3-9D76D790B303Q38046618-D80B1E13-31EA-465B-B71E-6336AA385DB0Q38083745-915DC0F9-62AC-4662-B139-06D4897A2A5DQ38207841-26409FEB-9874-40D5-ADA9-9DDF44FD7A3AQ38211744-34B9E610-2D09-4F65-9D75-3C45B11A97B1Q38349798-BFCCAB52-3351-4509-835C-FD47BAFD51EDQ38375202-9B47D42A-7622-4313-8A98-30CDC987D2C0Q39073986-A613CF0C-1AA4-4710-A038-04D4C7F1EE5EQ39586636-21171549-C773-495B-8074-1CBE53A18B65Q39716362-6670925A-9802-402B-A058-5B1D001C6F63Q41410574-B93B671E-1812-4776-8C05-55C673031066Q42256221-C26F1373-AD9C-464B-878B-5E640F06B0C0Q43833798-27F19635-D26D-4AF6-B05A-00D8C2CC1440Q45869181-A62A997B-6C73-40E5-8AC4-3092E6A9A497Q50940025-1E293B2F-A351-49DC-A69C-6BE97698F73D
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Angiotensin-converting enzyme 2: the first decade.
@ast
Angiotensin-converting enzyme 2: the first decade.
@en
type
label
Angiotensin-converting enzyme 2: the first decade.
@ast
Angiotensin-converting enzyme 2: the first decade.
@en
prefLabel
Angiotensin-converting enzyme 2: the first decade.
@ast
Angiotensin-converting enzyme 2: the first decade.
@en
P2860
P356
P1476
Angiotensin-converting enzyme 2: the first decade.
@en
P2093
Anthony J Turner
Nicola E Clarke
P2860
P304
P356
10.1155/2012/307315
P577
2011-11-10T00:00:00Z